3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
7
Carcinoma, Non-Small-Cell Lung
7
Pancreatic Neoplasms
5
Ovarian Neoplasms
5
Fallopian Tube Neoplasms
5
Endometrial Neoplasms
5
Breast Neoplasms
5
Neoplasm Metastasis
4
Adenocarcinoma Of Esophagus
4
Triple Negative Breast Neoplasms
3
Esophageal Neoplasms
3
Cholangiocarcinoma
3
Squamous Cell Carcinoma of Head and Neck
2
Melanoma
2
Esophageal Squamous Cell Carcinoma
2
Colorectal Neoplasms
2
Carcinoma, Transitional Cell
2
Brenner Tumor
2
Urinary Bladder Neoplasms
1
Small Cell Lung Carcinoma
1
Sinonasal Squamous Cell Carcinoma
1
Rectal Neoplasms
1
Pancreatic Cystic Neoplasm
1
Oropharyngeal Neoplasms
1
Neoplasms
1
Mouth Neoplasms
1
Metastatic Pancreatic Ductal Adenocarcinoma
1
Locally Advanced Cervical Adenocarcinoma
1
Laryngeal Neoplasms
1
Gallbladder Neoplasms
1
Interventions
pembrolizumab
2
N-(2-amino-5-fluorobenzyl)-4-(N-(pyridine-3-acrylyl)aminomethyl)benzamide
2
Gemcitabine
2
somatostatin, cyclic hexapeptide(Phe-Phe-Trp-Lys-Thr-Phe)-
1
sodium-iodide symporter
1
fludarabine
1
duvelisib
1
cemiplimab
1
X-Rays
1
Specimen Handling
1
Photons
1
Oxaliplatin
1
Magnetic Resonance Spectroscopy
1
Immunoglobulin G
1
Disulfides
1
Cyclophosphamide
1
Brentuximab Vedotin
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, T-Cell, Peripheral
×
Taxes
×
30 days
×
Clear all
No trials found.